U.S. markets close in 25 minutes
  • S&P 500

    3,828.63
    -71.48 (-1.83%)
     
  • Dow 30

    30,995.32
    -442.94 (-1.41%)
     
  • Nasdaq

    11,218.27
    -306.28 (-2.66%)
     
  • Russell 2000

    1,744.24
    -27.50 (-1.55%)
     
  • Crude Oil

    111.81
    +2.24 (+2.04%)
     
  • Gold

    1,821.20
    -3.60 (-0.20%)
     
  • Silver

    20.76
    -0.40 (-1.90%)
     
  • EUR/USD

    1.0527
    -0.0059 (-0.56%)
     
  • 10-Yr Bond

    3.2060
    +0.0120 (+0.38%)
     
  • GBP/USD

    1.2185
    -0.0085 (-0.69%)
     
  • USD/JPY

    136.1640
    +0.7180 (+0.53%)
     
  • BTC-USD

    20,318.80
    -513.13 (-2.46%)
     
  • CMC Crypto 200

    441.99
    -8.08 (-1.79%)
     
  • FTSE 100

    7,323.41
    +65.09 (+0.90%)
     
  • Nikkei 225

    27,049.47
    +178.20 (+0.66%)
     

Is it a Great Move to Invest in Core Laboratories (CLB)?

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Harding Loevner, an investment management firm, published its “International Small Companies Equity Fund” first-quarter 2022 investor letter – a copy of which can be downloaded here. The International Small Companies composite declined 13.4% gross of fees in the first quarter, well beyond the 6.4% decline of the MSCI ACWI ex-US Small Cap Index. The portfolio’s concentration in expensive stocks, a hazard of our commitment to investing in the stocks of high-quality rapidly growing businesses, hurt relative performance in a quarter during which investors fled from richly priced companies. Try to spend some time taking a look at the fund’s top 5 holdings to be informed about their best picks for 2022.

In its Q1 2022 investor letter, Harding Loevner International Small Companies Equity Fund mentioned Core Laboratories N.V. (NYSE:CLB) and explained its insights for the company. Founded in 1936, Core Laboratories N.V. (NYSE:CLB) is an Amsterdam, Netherlands-based petroleum industry company with a $969.1 million market capitalization. Core Laboratories N.V. (NYSE:CLB) delivered a -6.23% return since the beginning of the year, while its 12-month returns are down by -52.32%. The stock closed at $20.92 per share on June 21, 2022.

Here is what Harding Loevner International Small Companies Equity Fund has to say about Core Laboratories N.V. (NYSE:CLB) in its Q1 2022 investor letter:

"There were some bright spots in Energy, where Netherlands-based (and US-listed) energy services company Core Laboratories (NYSE:CLBsaw a boost from rising oil prices and increased spending on oil and gas exploration and production."

Oil, Gas

Our calculations show that Core Laboratories N.V. (NYSE:CLB) fell short and didn’t make it on our list of the 30 Most Popular Stocks Among Hedge Funds. Core Laboratories N.V. (NYSE:CLB) was in 16 hedge fund portfolios at the end of the first quarter of 2022, compared to 15 funds in the previous quarter. Core Laboratories N.V. (NYSE:CLB) delivered a -28.60% return in the past 3 months.

In March 2022, we also shared another hedge fund’s views on Core Laboratories N.V. (NYSE:CLB) in another article. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters 2022 Q1 page.

Disclosure: None. This article is originally published at Insider Monkey.